Hematology

Top Story

Hyperthyroidism linked to lower recurrent VTE risk among elderly patients

June 29, 2016

Older patients with subclinical hyperthyroidism appeared at lower risk for recurrent venous thromboembolism, according to the results of a prospective cohort study conducted in Switzerland.

Although hypothyroidism appeared associated with recurrent VTE, the association did not reach statistical significance and it did not demonstrate differences in thrombophilic biomarkers, results showed.

In the Journals

Outcomes, treatment strategies vary among patients with upper extremity venous thrombosis

June 24, 2016
The risk for recurrent venous thromboembolism appeared low for patients with upper extremity deep vein thrombosis and almost nonexistent for patients with upper…
In the Journals

Edoxaban safe, effective for extended prevention of recurrent VTE

June 20, 2016
Extended treatment with the oral anticoagulant edoxaban prevented recurrent venous thromboembolism and led to fewer major bleeding events than warfarin among patients…
In the Journals

Riociguat safe, tolerable in chronic thromboembolic pulmonary hypertension

June 16, 2016
Patients with chronic thromboembolic pulmonary hypertension tolerated long-term use of riociguat well, according to recent data, and researchers identified two…
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
At Issue

VIDEO: Wide array of therapeutic options in myeloma a ‘wonderful problem’ for hematologists

May 19, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
In the Journals

Hyperthyroidism linked to lower recurrent VTE risk among elderly patients

June 29, 2016
Older patients with subclinical hyperthyroidism appeared at lower risk for recurrent venous thromboembolism, according to the results of a…

In the Journals

Outcomes, treatment strategies vary among patients with upper extremity venous thrombosis

June 24, 2016
The risk for recurrent venous thromboembolism appeared low for patients with upper extremity deep vein thrombosis and almost nonexistent for patients…

In the Journals

Edoxaban safe, effective for extended prevention of recurrent VTE

June 20, 2016
Extended treatment with the oral anticoagulant edoxaban prevented recurrent venous thromboembolism and led to fewer major bleeding events than…

In the Journals

Riociguat safe, tolerable in chronic thromboembolic pulmonary hypertension

June 16, 2016
Patients with chronic thromboembolic pulmonary hypertension tolerated long-term use of riociguat well, according to recent data, and researchers…

In the Journals

Unknown risk factors contribute to risk for major bleeds during VKA therapy

June 15, 2016
The risk for major bleeding associated with prior minor bleeding during treatment with vitamin K antagonists appeared linked to fixed, still unknown…

Meeting News CoverageVideo

VIDEO: Treatment of patients with cancer-associated thrombosis an ‘evolving paradigm’

June 14, 2016
CHICAGO — Alok A. Khorana, MD, professor of medicine at Cleveland Clinic Lerner College of Medicine, vice chair for clinical services of…

In the Journals

Betrixaban may reduce VTE risk in certain patients with acute illness

June 13, 2016
The primary efficacy outcome of the APEX trial was not met, but exploratory analyses suggest that extended-duration thromboprophylaxis with Factor Xa…

At IssueVideo

VIDEO: Peter Voorhees, MD, reviews ‘extremely important’ proteasome inhibition data from ENDEAVOR

June 9, 2016
Peter Voorhees, MD, director of the myeloma program at the University of North Carolina in Chapel Hill and associate professor at the University of…

Meeting News Coverage

Longer anticoagulation therapy may reduce VTE recurrence in patients with cancer

June 8, 2016
CHICAGO — Extending anticoagulation beyond 3 months reduced risk for recurrent clots in patients with cancer, according to results presented at…

At IssueVideo

VIDEO: Array of FDA myeloma drug approvals, new research steer field in filling ‘unmet medical need’

June 2, 2016
Ajai Chari, MD, director of Clinical Research in the Multiple Myeloma Program, Icahn School of Medicine at Mount Sinai in New York, discusses…

More Headlines »
morganatic-roan
morganatic-roan